First New York Securities’s Boston Scientific BSX Stock Holding History

First New York Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-188	Closed	-$6.39K	–	225
2016 Q1	$6.39K	Buy	+188	New	+$3.3K	﹤0.01%	195

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First New York Securities's BSX Position: Q4 2016 in Review

First New York Securities sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 660 shares — an estimated $15.7K sold.

First New York Securities first reported a position in BSX in Q2 2013 and held it in 4 quarters. The position peaked at $65K in Q3 2013. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

First New York Securities reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
First New York Securities sold 660 Boston Scientific shares in Q4 2016, an estimated $15.7K.
First New York Securities first reported a position in Boston Scientific in Q2 2013 and held it in 4 quarters.
First New York Securities's Boston Scientific position peaked at $65K in Q3 2013.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.